Astera Labs got a warm reception in its Wall Street debut Wednesday, giving investors yet another hot chip play to consider.
Barclays analyst Tom O’Malley raised the firm’s price target on Astera Labs (ALAB) to $135 from $87 and keeps an Overweight rating on the shares as part of a 2025 outlook for the ...
Morgan Stanley downgraded Astera Labs (NASDAQ:ALAB) to Equal-weight from Overweight due to full valuation and priced-in product ramps. The firm noted that Astera's stock is approaching its price ...
To get a sense of who is truly in control of Astera Labs, Inc. (NASDAQ:ALAB), it is important to understand the ownership structure of the business. We can see that institutions own the lion's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results